News | Managed Healthcare Executive

Three Pharmacy Regulations Health Execs Should Watch

June 5, 2018

Edward Buthusiem comments on the Orphan Drug Act designation and its benefits and incentives; the volume and costs of producing and selling orphan drugs; and the pending Closing Loopholes for Orphan Drugs Act.

Read the article.

BRG Experts

Related Professionals

Edward J. Buthusiem

Managing Director

Washington, DC